Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow
Monaco, A.P.; Wood, M.L.; Maki, T.; Hartner, W.; De Fazio, S.; Gozzo, J.J.
Transplantation Proceedings 20(3 Suppl 3): 36-48
1988
ISSN/ISBN: 0041-1345 PMID: 2968700 Document Number: 323949
Document emailed within 1 workday
Related Documents
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364Hara, Y.; Matsuura, T.; Imanishi, M.; Tahara, H.; Kurita, T. 1994: Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression Transplantation Proceedings 26(6): 3226-3228
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044
Hall, B.M.; Jelbart, M.E.; Dorsch, S.E. 1985: Specific unresponsiveness to allografts induced by cyclosporine is not antibody dependent Transplantation Proceedings 17(2): 1650-1652
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Hale, D.A.; Gottschalk, R.; Maki, T.; Monaco, A.P. 1998: Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 65(4): 473-479
Monaco, A.P.; Clark, A.W.; Wood, M.L.; Sahyoun, A.I.; Codish, S.D.; Brown, R.W. 1976: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt Surgery 79(4): 384-392
Watanabe, K.; Yuge, K.; Sato, K.; Yamagishi, K.; Sonoda, K.; Masaki, Y.; Maruyama, S.; Takahara, H.; Matsubayashi, T.; Yago, K. 1989: Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion Transplantation Proceedings 21(1 Part 1): 1112-1115
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Timchenko, A.S.; Skuratovskiĭ, M.F. 1978: Immunosuppressive properties of antilymphocyte serum obtained ALS-resistant rat bone marrow lymphocytes Fiziolohichnyi Zhurnal 24(4): 472-475
Fukuzaki, T.; Gotoh, M.; Monden, M.; Dono, K.; Ohta, Y.; Nishihara, M.; Hasuike, Y.; Kanai, T.; Miyasaka, M.; Mori, T. 1995: Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506 Transplantation Proceedings 27(1): 354
Li, Y.; Chang, Y.; Xu, L.; Zhang, X.; Huang, X. 2014: Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests Chinese Medical Journal 127(20): 3597-3601
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Arima, T.; Lehmann, M.; Flye, M.W. 1997: Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen Transplantation 63(2): 284-292
Gruessner, R.W.; Uckun, F.M.; Pirenne, J.; Nakhleh, R.E.; Benedetti, E.; Bekersky, I.; Troppmann, C.; Gruessner, A.C. 1997: Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation Transplantation 63(1): 12-20
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Duraj, F.F.; Bäckman, L.; Dati, F.; Ringdén, O. 1990: Monitoring low molecular weight serum proteins in cyclosporine A-treated bone marrow transplant recipients Transplantation Proceedings 22(1): 203-204
Monaco, A.P.; Wood, M.L.; Maki, T.; Gozzo, J.J. 1989: Future strategies in immunosuppression: problems and potential for the induction of specific unresponsiveness to organ allografts in clinical transplantation Transplantation Proceedings 21(6): 3939-3942
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196